wwno.org
Vagus nerve stimulation may tame autoimmune diseases
This article describes implantable vagus nerve stimulators being studied as a way to reduce inflammation in autoimmune diseases, including Crohn’s disease. If effective, these devices could offer a non-drug option or complement to current immune-suppressing treatments.
Adult patients with inflammatory bowel disease or other autoimmune diseases, clinicians managing IBD, researchers in bioelectronic medicine, and patients considering alternatives to biologic immunosuppressants.
What To Know
What to know This article reports on research into vagus nerve stimulation (VNS) as a potential non-drug approach to reduce inflammation in autoimmune diseases.
It describes implanted electrical stimulators (devices) being studied for conditions including rheumatoid arthritis and Crohn's disease, and notes a device from SetPoint Medical under FDA review based on a 2024 study.
The piece explains the basic science: signals in the vagus nerve can trigger a brain–body reflex that reduces cytokine production and tampers down inflammation, and researchers have developed ways to record and stimulate those signals.
It summarizes early clinical results in rheumatoid arthritis and mentions ongoing interest in VNS as an alternative or adjunct to immune-suppressing drugs. It does not provide treatment advice or specific patient recommendations.
If you or a loved one are considering device-based treatment, talk with your clinician about the current evidence, regulatory status, possible risks, and how it compares with approved medical therapies.
The story covers early-stage and emerging clinical research and a regulatory review for a device in rheumatoid arthritis; it does not establish that VNS is an approved or proven treatment for Crohn’s disease. Read the original NPR report for study details and check regulatory decisions and clinical guidelines before changing care.
